Medicolegal issues surrounding devices and mesh for surgical treatment of prolapse and incontinence. [Review]

Available online from MWHC library: March 1996 - present, Available in print through MWHC library: 1999 - March 2003

Legal issues related to vaginal mesh devices for prolapse and incontinence include abnormal injury and inadequate informed consent. Although vaginal mesh devices are currently cleared through the 510(k) process, new developments at the US Food and Drug Administration requiring additional postmarket studies (522 studies) for transvaginal mesh for prolapse and mini-suburethral synthetic slings have been issued to ensure product safety and effectiveness. New initiatives including unique device identification numbers and the Pelvic Floor Disorders Registry have been developed to improve surveillance throughout the total product/device life cycle.


Englishhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00003081-201306000-00003&LSLINK=80&D=ovft

0009-9201


*Informed Consent
*Pelvic Organ Prolapse/su [Surgery]
*Surgical Mesh
*Urinary Incontinence/su [Surgery]
Female
Gynecology/ed [Education]
Humans
Malpractice/lj [Legislation & Jurisprudence]
Postoperative Complications
Product Surveillance, Postmarketing
Prostheses and Implants/ae [Adverse Effects]
Risk Factors
Surgical Mesh/ae [Adverse Effects]
United States


MedStar Washington Hospital Center


Obstetrics and Gynecology/Female Pelvic Medicine and Reconstructive Surgery


Journal Article
Review